The Covid-19 pandemic and its impacts on patients with Diabetes Mellitus




Diabetes mellitus; Covid-19; Coronavirus; SARS-CoV-2.


Introduction: After the detection of SARS-CoV-2 in the city of Wuhan, China, the World Health Organization (WHO) recognized the new Coronavirus infection as a serious public health problem and in March 2020 characterized it as a pandemic. Given this situation, some population groups were considered at high risk for severe cases of Covid-19, including patients with Diabetes mellitus, a clinical condition of high prevalence in the world population. Objective: This study analyzed how the new Coronavirus pandemic affected adult and elderly patients with diabetes mellitus and whether the literature was able to observe the difference in outcomes according to the control measures adopted in each country. Method: A literature review was carried out from the electronic databases PubMed, Virtual Health Library (VHL) and Google Scholar using the keywords “Diabetes mellitus”, “Covid-19”, “Sars Cov 2”, “Coronavirus”, “Adults”. Results: There were 19 studies included in this review. It was observed that diabetes is an important risk factor for Covid-19, with a higher probability of severe disease with the need for invasive mechanical ventilation and higher mortality. The strict and structured confinement had less impact on glycemic control, whereas in countries that did not adopt it, it was possible to observe a deterioration in the glycemic control of patients. Conclusion: Patients with diabetes, especially those with poor glycemic control, are more exposed to the most serious complications of Covid-19. Adequate compliance with social isolation measures was a protective factor for good glycemic control.


Alharthi, S. K., Alyusuf, E. Y., Alguwaihes, A. M., Alfadda, A., & Al-Sofiani, M. E. (2021). The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia. Diabetes Research and Clinical Practice, 173, 108682.

Alkundi, A., Mahmoud, I., Musa, A., & Naveed, S. (2020). Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study.

Aquino, J. A., Baldoni, A. O., Di Lorenzo Oliveira, C., Cardoso, C. S., de Figueiredo, R. C., & Sanches, C. (2019). Pharmacotherapeutic empowerment and its effectiveness in glycemic control in patients with Diabetes Mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13(1), 137–142.

Barrett, C. E., Park, J., Kompaniyets, L., Baggs, J., Cheng, Y. J., Zhang, P., Imperatore, G., & Pavkov, M. E. (2021). Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in the U.S. Diabetes Care, 44(8), 1788–1796.

Biamonte, E., Pegoraro, F., Carrone, F., Facchi, I., Favacchio, G., Lania, A. G., Mazziotti, G., & Mirani, M. (2021). Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine, 72(3), 604–610.

Bonora, B. M., Boscari, F., Avogaro, A., Bruttomesso, D., & Fadini, G. P. (2020). Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Therapy, 11(6), 1369–1379.

Borzouei, S., Mohammadian-khoshnoud, M., Omidi, T., Bashirian, S., Bahreini, F., Heidarimoghadam, R., & Khazaei, S. (2021). Predictors of COVID-19 related death in diabetes patients: A case-control study in Iran. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 15(4).

Chan, K. H., Thimmareddygari, D., Ramahi, A., Atallah, L., Baranetsky, N. G., & Slim, J. (2020). Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series. Diabetes Research and Clinical Practice, 166, 108279.

Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology, 39(5), 529–539.

Deng, Y., Xie, W., Liu, T., Wang, S., Zan, Y., Wang, M., Meng, X., Zheng, J., Xiong, H., & Fu, X. (2021). Association of diabetes with severity and mortality in hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective study. Archives of Endocrinology and Metabolism.

England, N. H. S., Holman, N., Keefe, J. O., & Curley, M. (n.d.). Pr ep rin pe er r ev ed Pr ep rin t n ot pe er ed.

Gao, Y. dong, Ding, M., Dong, X., Zhang, J. jin, Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y. li, Fu, W., Li, W., Liang, H. ling, Cao, Y. yuan, Yan, Q., Cao, C., Gao, H. yu, Brüggen, M. C., van de Veen, W., Sokolowska, M., Akdis, M., & Akdis, C. A. (2021). Risk factors for severe and critically ill COVID-19 patients: A review. In Allergy: European Journal of Allergy and Clinical Immunology (Vol. 76, Issue 2).

Howick, J (2011). OCEBM Levels of Evidence Working Group. "The Oxford 2011 Levels of Evidence

Jayaweera, M., Perera, H., Gunawardana, B., & Manatunge, J. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Envronmental Research, 188(January), 1–18.

Kaminska, H., Szarpak, L., Kosior, D., Wieczorek, W., Szarpak, A., Al-Jeabory, M., Gawel, W., Gasecka, A., Jaguszewski, M. J., & Jarosz-Chobot, P. (2021). Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis. Acta Diabetologica, 58(8), 1101– 1110.

khare, J., & jindal, S. (2020). Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(6), 1571–1574.

Landstra, C. P., & de Koning, E. J. P. (2021). COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Frontiers in Endocrinology, 12(June), 1–18.

Lepelletier.D Michael J. Smart, Robert B. Noland, G. B. (2020). Repercusión del confinamiento por COVID-19 sobre el control glucémico en ni˜nos y adolescentes con diabetes mellitus tipo 1. Ann Oncol, January, 19–21.

Li, H., Tian, S., Chen, T., Cui, Z., Shi, N., Zhong, X., Qiu, K., Zhang, J., Zeng, T., Chen, L., & Zheng, J. (2020). Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes, Obesity and Metabolism, 22(10), 1897–1906.

Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., & Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. International Journal of Clinical Pharmacy, 42(2), 299–304.

Merzon, E., Green, I., Shpigelman, M., Vinker, S., Raz, I., Golan-Cohen, A., & Eldor, R. (2021). Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes. Diabetes/Metabolism Research and Reviews, 37(5).

Mesa, A., Viñals, C., Pueyo, I. I., Roca, D., Vidal, M., Giménez, M., & Conget, I. (2020). The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Research and Clinical Practice, 167, 1–5.

Minuto, N., Bassi, M., Montobbio, C., Vinci, F., Mercuri, C., Perri, F. N., Cabri, M., Calevo, M. G., d’Annunzio, G., & Maghnie, M. (2021). The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes. Frontiers in Endocrinology, 12(July), 1– 9.

Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021). COVID-19: Virology, biology and novel laboratory diagnosis. Journal of Gene Medicine, 23(2), 1–11.

Ortega, E., Corcoy, R., Gratacòs, M., Cos Claramunt, F. X., Mata-Cases, M., Puig-Treserra, R., Real, J., Vlacho, B., Castelblanco, E., Domingo, P., Khunti, K., Franch-Nadal, J., & Mauricio, D. (2021). Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: A cross-sectional database study. BMJ Open, 11(7), 1–10.

Ramchandani, N. (2019). Virtual Coaching to Enhance Diabetes Care. Diabetes Technology and Therapeutics, 21(S2), S2-48-S2-51.

Sharif, N., Ahmed, S. N., Opu, R. R., Tani, M. R., Dewan, D., Daullah, M. U., Shanto, R. I., Parvez, A. K., Talukder, A. A., & Dey, S. K. (2021). Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 15(3), 1009–1016.

Tanji, Y., Sawada, S., Watanabe, T., Mita, T., Kobayashi, Y., Murakami, T., Metoki, H., & Akai, H. (2021). Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Research and Clinical Practice, 176, 108840.

Ugliara Barone, M. T., Harnik, S. B., Chaluppe, M., Vieira de Luca, P., Ngongo, B., Pedrosa, H. C., Pirolo, V., Franco, D. R., Malta, D. C., & Giampaoli, V. (2020). Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(6), 1973–1978.

Umakanthan, S., Sahu, P., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahao-Machado, L. F., Dahal, S., Kumar, H., & Kv, D. (2020). Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgraduate Medical Journal, 96(1142), 753–758.

Verma, A., Rajput, R., Verma, S., Balania, V. K. B., & Jangra, B. (2020). Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), 1213–1216.

WHO Coronavírus (COVID-19) Dashboard, (2021). Referência dos dados epidemiológicos atualizados

Wu, J., Zhang, J., Sun, X., Wang, L., Xu, Y., Zhang, Y., Liu, X., & Dong, C. (2020). Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes, Obesity and Metabolism, 22(10), 1907–1914.

Wu, Z. hong, Tang, Y., & Cheng, Q. (2021). Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetologica, 58(2), 139–144.



How to Cite

ROSA, M. R. S. .; GONÇALVES, A. C. O. The Covid-19 pandemic and its impacts on patients with Diabetes Mellitus . Research, Society and Development, [S. l.], v. 11, n. 3, p. e34711326512, 2022. DOI: 10.33448/rsd-v11i3.26512. Disponível em: Acesso em: 17 jun. 2024.



Review Article